Speaker Profile
M.D., Ph.D., Professor of Medicine, MD Anderson Cancer Ctr.
Biography
Dr. Tsimberidou is a Professor of Medical Oncology at MD Anderson. She has designed highly innovative clinical trials that have changed the standard of oncology practice. She pioneered the personalized medicine program for advanced cancer that improved patient care and established a model for clinical trials at other institutions, nationally and internationally. She led multiple clinical trials and has published 350 articles. She has been invited to present her work as a keynote speaker at national and international conferences. She has received many awards, including an ASCO Career Development Award. She chaired ASCO's Clinical Research Committee (2016-2017) and she was appointed as a member of other committees. Because of her accomplishments in personalized medicine, she was elected a Fellow of the American Association for the Advancement of Science (FAAAS) and for her contributions to ASCO, she received the designation of Fellow of ASCO (FASCO). She is a Katherine Russell Dixie Distinguished Endowed Professor.
Talk
Innovations in Precision Oncology: From Genomics to Therapy
The application of artificial intelligence (AI) and machine learning (ML) has accelerated advancements in Precision Oncology. AIML techniques in genomic, pathological, and radiomic evaluation enable a deep, fast, and precise understanding of tumor biology and have the potential to significantly accelerate the development of personalized therapies for patients with cancer.
Genomic Profiling Showcase:
MD Anderson
The mission of the University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate/graduate students, trainees, professionals, employees and the public.
Session Abstract – PMWC 2025 Silicon Valley
The PMWC 2025 Genomic Profiling Showcase will provide a 15-30 min speaking opportunity for selected companies working with the latest technologies in nucleic acid sequencing such as NGS, providing instrumentation for genomic sequencing, and offering direct to consumer services. These companies will share their innovative products and services to an audience of leading investors, potential clients and partners. The Genomic Profiling Showcase will exhibit the latest innovations in methods and instruments used for DNA/ RNA sequencing to ascertain the genomic and transcriptional profile of a person in order to understand why some people get certain diseases while others do not, or why people react in different ways to the same drug. This information is also being used to develop new ways to diagnose, treat, and prevent diseases, such as cancer.
